Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer

Human Molecular Genetics

Volumn 23, Issue 20, 2014, Pages 5545-5557

  Rafnar, Thorunn ^a   Sulem, Patrick ^a   Thorleifsson, Gudmar ^a   Vermeulen, Sita H ^b   Helgason, Hannes ^a,c   Saemundsdottir, Jona ^a   Gudjonsson, Sigurjon A ^a   Sigurdsson, Asgeir ^a   Stacey, Simon N ^a   Gudmundsson, Julius ^a   Johannsdottir, Hrefna ^a   Alexiusdottir, Kristin ^d   Petursdottir, Vigdis ^d   Nikulasson, Sigfus ^d   Geirsson, Gudmundur ^d   Jonsson, Thorvaldur ^c,d   Aben, Katja K H ^b,e   Grotenhuis, Anne J ^b   Verhaegh, Gerald W ^b   Dudek, Aleksandra M ^b   Alfred Witjes, J ^b   van der Heijden, Antoine G ^b   Vrieling, Alina ^b   Galesloot, Tessel E ^b   De Juan, Ana ^f   Panadero, Angeles ^g   Rivera, Fernando ^f   Hurst, Carolyn ^h   Timothy Bishop, D ⁱ   Sak, Sei C ^j   Choudhury, Ananya ^k   Teo, Mark T W ^h   Arici, Cecilia ^l   Carta, Angela ^l   Toninelli, Elena ^l   de Verdier, Petra ^m   Rudnai, Peter ⁿ   Gurzau, Eugene ^o   Koppova, Kvetoslava ^p   van der Keur, Kirstin A ^q   Lurkin, Irene ^q   Goossens, Mieke ^r   Kellen, Eliane ^r   Guarrera, Simonetta ^s   Russo, Alessia ^s,t   Critelli, Rossana ^s,t   Sacerdote, Carlotta ^s,u,v   Vineis, Paolo ^s,w   Krucker, Clémentine ^x,y   Zeegers, Maurice P ^z   Gerullis, Holger ^ab   Ovsiannikov, Daniel ^ac   Volkert, Frank ^ad   Hengstler, Jan G ^ae   Selinski, Silvia ^ae   Magnusson, Olafur T ^a   Masson, Gisli ^a   Kong, Augustine ^a,c   Gudbjartsson, Daniel ^a,c   Lindblom, Annika ^m   Zwarthoff, Ellen ^q   Porru, Stefano ^l   Golka, Klaus ^ae   Buntinx, Frank ^r,aa   Matullo, Giuseppe ^s,t   Kumar, Rajiv ^af   Mayordomo, José I ^ag   Gunnar Steineck, D ^ah,ai   Kiltie, Anne E ^aj   Jonsson, Eirikur ^d   Radvanyi, François ^x,y   Knowles, Margaret A ^h   Thorsteinsdottir, Unnur ^a,c   Kiemeney, Lambertus A ^b   Stefansson, Kari ^a,c   more..

^a DECODE GENETICS   (Iceland)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF ICELAND   (Iceland)

^d LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^e Netherlands Comprehensive Cancer Organisation The Netherlands   (Netherlands)

^f HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^g Hospital Ciudad de Coria   (Spain)

^h ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF LEEDS   (United Kingdom)

^j PINDERFIELDS GENERAL HOSPITAL   (United Kingdom)

^k CHRISTIE HOSPITAL   (United Kingdom)

^l UNIVERSITY OF BRESCIA   (Italy)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH   (Hungary)

^o BABE BOLYAI UNIVERSITY   (Romania)

^p Regional Authority of Public Health   (Slovakia)

^q ERASMUS MEDICAL CENTER   (Netherlands)

^r UNIVERSITY OF LEUVEN   (Belgium)

^s Human Genetics Foundation   (Italy)

^t UNIVERSITY OF TURIN   (Italy)

^u UNIVERSITY OF TURIN   (Italy)

^v Centre for Cancer Epidemiology and Prevention (CPO Piemonte)   (Italy)

^w IMPERIAL COLLEGE LONDON   (United Kingdom)

^x INSTITUT CURIE   (France)

^y INSTITUT CURIE   (France)

^z MAASTRICHT UNIVERSITY   (Netherlands)

^aa MAASTRICHT UNIVERSITY   (Netherlands)

^ab Lukasklinik Neuss ^*  (Germany)

^ac St Josefs Hospital Dortmund Hörde   (Germany)

^ad Paul Gerhardt Foundation   (Germany)

^ae LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^af GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ag UNIVERSITY OF ZARAGOZA   (Spain)

^ah KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ai SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^aj UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR; CALCIUM BINDING PROTEIN; MEMBRANE PROTEIN; SERRATE PROTEINS; SIGNAL PEPTIDE;

ALLELISM; ARTICLE; BLADDER CANCER; CHROMOSOME 20P; CONTROLLED STUDY; GENE FREQUENCY; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; ADULT; AGED; BLADDER TUMOR; CASE CONTROL STUDY; CAUCASIAN; CHROMOSOME 20; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEINS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 20; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; URINARY BLADDER NEOPLASMS;

EID: 84903486573     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu264     Document Type: Article

References (57)

1. Ploeg, M., Aben, K.K.H. and Kiemeney, L.A. (2009) The present and future burden of urinary bladder cancer in the world. World J. Urol., 27, 289-293.
2. Ferlay, J., Shin, H.-R., Bray, F., Forman, D., Mathers, C. and Parkin, D.M. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer J. Int. Cancer, 127, 2893-2917.
3. Howlader, N., Noone, A.M., Krapcho, M., Garshell, J., Neyman, N., Altekruse, S.F., Kosary, C.L., Yu, M., Ruhl, J., Tatalovich, Z. et al. SEER Cancer Statistics Review 1975-2010. National Cancer Institute, Bethesda, MD, USA.
4. Aben, K.K.H., Witjes, J.A., Schoenberg, M.P., Hulsbergen-van de Kaa, C., Verbeek, A.L.M. and Kiemeney, L.A.L.M. (2002) Familial aggregation of urothelial cell carcinoma. Int. J. Cancer J. Int. Cancer, 98, 274-278.
5. Murta-Nascimento, C., Silverman, D.T., Kogevinas, M., García-Closas, M., Rothman, N., Tardón, A., García-Closas, R., Serra, C., Carrato, A., Villanueva, C. et al. (2007) Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol., 16, 1595-1600.
6. Dong, C. and Hemminki, K. (2001) Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int. J. Cancer J. Int. Cancer, 92, 144-150.
7. Aben, K.K.H., Baglietto, L., Baffoe-Bonnie, A., Coebergh, J.-W.W., Bailey-Wilson, J.E., Trink, B., Verbeek, A.L.M., Schoenberg, M.P., Alfred Witjes, J. and Kiemeney, L.A. (2006) Segregation analysis of urothelial cell carcinoma. Eur. J. Cancer Oxf. Engl., 42, 1428-1433.
8. García-Closas, M., Malats, N., Silverman, D., Dosemeci, M., Kogevinas, M., Hein, D.W., Tardón, A., Serra, C., Carrato, A., García-Closas, R. et al. (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet, 366, 649-659.
9. Kiemeney, L.A., Thorlacius, S., Sulem, P., Geller, F., Aben, K.K.H., Stacey, S.N., Gudmundsson, J., Jakobsdottir, M., Bergthorsson, J.T., Sigurdsson, A. et al. (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet., 40, 1307-1312.
10. Wu, X., Ye, Y., Kiemeney, L.A., Sulem, P., Rafnar, T., Matullo, G., Seminara, D., Yoshida, T., Saeki, N., Andrew, A.S. et al. (2009) Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat. Genet., 41, 991-995.
11. Kiemeney, L.A., Sulem, P., Besenbacher, S., Vermeulen, S.H., Sigurdsson, A., Thorleifsson, G., Gudbjartsson, D.F., Stacey, S.N., Gudmundsson, J., Zanon, C. et al. (2010)Asequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat. Genet., 42, 415-419.
12. Rothman, N., Garcia-Closas, M., Chatterjee, N., Malats, N., Wu, X., Figueroa, J.D., Real, F.X., Van Den Berg, D., Matullo, G., Baris, D. et al. (2010) A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat. Genet., 42, 978-984.
13. Rafnar, T., Vermeulen, S.H., Sulem, P., Thorleifsson, G., Aben, K.K., Witjes, J.A., Grotenhuis, A.J., Verhaegh, G.W., Hulsbergen-van de Kaa, C.A., Besenbacher, S. et al. (2011) Europeangenome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum. Mol. Genet., 20, 4268-4281.
14. Garcia-Closas, M., Ye, Y., Rothman, N., Figueroa, J.D., Malats, N., Dinney, C.P., Chatterjee, N., Prokunina-Olsson, L., Wang, Z., Lin, J. et al. (2011) A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum. Mol. Genet., 20, 4282-4289.
15. Figueroa, J.D., Ye, Y., Siddiq, A., Garcia-Closas, M., Chatterjee, N., Prokunina-Olsson, L., Cortessis, V.K., Kooperberg, C., Cussenot, O., Benhamou, S. et al. (2013) Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum. Mol. Genet., 23, 1387-1398. doi:10.1093/hmg/ddt519.
16. Kong, A., Masson, G., Frigge, M.L., Gylfason, A., Zusmanovich, P., Thorleifsson, G., Olason, P.I., Ingason, A., Steinberg, S., Rafnar, T. et al. (2008) Detection of sharing by descent, long-range phasing and haplotype imputation. Nat. Genet., 40, 1068-1075.
17. Kong, A., Steinthorsdottir, V., Masson, G., Thorleifsson, G., Sulem, P., Besenbacher, S., Jonasdottir, A., Sigurdsson, A., Kristinsson, K.T., Jonasdottir, A. et al. (2009) Parental origin of sequence variants associated with complex diseases. Nature, 462, 868-874.
18. Styrkarsdottir, U., Thorleifsson, G., Sulem, P., Gudbjartsson, D.F., Sigurdsson, A., Jonasdottir, A., Jonasdottir, A., Oddsson, A., Helgason, A., Magnusson, O.T. et al. (2013) Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits. Nature, 497, 517-520.
19. Kong, A., Thorleifsson, G., Gudbjartsson, D.F., Masson, G., Sigurdsson, A., Jonasdottir, A., Walters, G.B., Jonasdottir, A., Gylfason, A., Kristinsson, K.T. et al. (2010) Fine-scale recombination rate differences between sexes, populations and individuals. Nature, 467, 1099-1103.
20. Pruim, R.J., Welch, R.P., Sanna, S., Teslovich, T.M., Chines, P.S., Gliedt, T.P., Boehnke, M., Abecasis, G.R. and Willer, C.J. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics, 26, 2336-2337.
21. Knowles, M.A. (2006) Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis, 27, 361-373.
22. Lobry, C., Oh, P. and Aifantis, I. (2011) Oncogenic and tumor suppressor functions of Notch in cancer: it'sNOTCHwhat you think. J. Exp. Med., 208, 1931-1935.
23. Shi, T., Xu, H., Wei, J., Ai, X., Ma, X., Wang, B., Ju, Z., Zhang, G., Wang, C., Wu, Z. et al. (2008) Association of low expression of notch-1 and jagged-1 in humanpapillary bladder cancer and shorter survival. J. Urol., 180, 361-366.
24. Vallot, C., Stransky, N., Bernard-Pierrot, I., Hérault, A., Zucman-Rossi, J., Chapeaublanc, E., Vordos, D., Laplanche, A., Benhamou, S., Lebret, T. et al. (2011) A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression. J. Natl. Cancer Inst., 103, 47-60.
25. Rosenbloom, K.R., Sloan, C.A., Malladi, V.S., Dreszer, T.R., Learned, K., Kirkup, V.M., Wong, M.C., Maddren, M., Fang, R., Heitner, S.G. et al. (2013)ENCODEdata in theUCSCGenomeBrowser: year 5 update. Nucleic Acids Res., 41, D56-D63.
26. Meyer, L.R., Zweig, A.S., Hinrichs, A.S., Karolchik, D., Kuhn, R.M., Wong, M., Sloan, C.A., Rosenbloom, K.R., Roe, G., Rhead, B. et al. (2013) The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res., 41, D64-D69.
27. Ward, L.D. and Kellis, M. (2012) HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res., 40, D930-D934.
28. Boyle, A.P., Hong, E.L., Hariharan, M., Cheng, Y., Schaub, M.A., Kasowski, M., Karczewski, K.J., Park, J., Hitz, B.C., Weng, S. et al. (2012) Annotation of functional variation in personal genomes using RegulomeDB. Genome Res., 22, 1790-1797.
29. Ng, S.B., Turner, E.H., Robertson, P.D., Flygare, S.D., Bigham, A.W., Lee, C., Shaffer, T., Wong, M., Bhattacharjee, A., Eichler, E.E. et al. (2009) Targeted capture and massively parallel sequencing of 12 human exomes. Nature, 461, 272-276.
30. Kung, A.W.C., Xiao, S.-M., Cherny, S., Li, G.H.Y., Gao, Y., Tso, G., Lau, K.S., Luk, K.D.K., Liu, J., Cui, B. et al. (2010) Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies. Am. J. Hum. Genet., 86, 229-239.
31. Estrada, K., Styrkarsdottir, U., Evangelou, E., Hsu, Y.-H., Duncan, E.L., Ntzani, E.E., Oei, L., Albagha, O.M.E., Amin, N., Kemp, J.P. et al. (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat. Genet., 44, 491-501.
32. International Consortium for Blood Pressure Genome-Wide Association Studies, Ehret, G.B., Munroe, P.B., Rice, K.M., Bochud, M., Johnson, A.D., Chasman, D.I., Smith, A.V., Tobin, M.D., Verwoert, G.C. et al. (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature, 478, 103-109.
33. Espinoza, I. and Miele, L. (2013) Notch inhibitors for cancer treatment. Pharmacol. Ther., 139, 95-110.
34. Lukk, M., Kapushesky, M., Nikkilä, J., Parkinson, H., Goncalves, A., Huber, W., Ukkonen, E. and Brazma, A. (2010) A global map of human gene expression. Nat. Biotechnol., 28, 322-324.
35. The Cancer Genome Atlas Research Network. (2014) Comprehensive molecular characterization of urothelial bladder carcinoma. Nature, 507, 315-322. doi:10.1038/nature12965.
36. Hirao, S., Hirao, T., Marsit, C.J., Hirao, Y., Schned, A., Devi-Ashok, T., Nelson, H.H., Andrew, A., Karagas, M.R. and Kelsey, K.T. (2005) Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer. Cancer, 104, 1918-1923.
37. Wetzels, J.F.M., Kiemeney, L.A.L.M., Swinkels, D.W., Willems, H.L. and den Heijer, M. (2007) Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int., 72, 632-637.
38. Sak, S.C., Barrett, J.H., Paul, A.B., Bishop, D.T. and Kiltie, A.E. (2005) The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder. Br. J. Cancer, 92, 2262-2265.
39. Matullo, G., Guarrera, S., Sacerdote, C., Polidoro, S., Davico, L., Gamberini, S., Karagas, M., Casetta, G., Rolle, L., Piazza, A. et al. (2005) Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol., 14, 2569-2578.
40. Shen, M., Hung, R.J., Brennan, P., Malaveille, C., Donato, F., Placidi, D., Carta, A., Hautefeuille, A., Boffetta, P. and Porru, S. (2003) Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol., 12, 1234-1240.
41. Kellen, E., Zeegers, M., Paulussen, A., Van Dongen, M. and Buntinx, F. (2006) Fruit consumption reduces the effect of smoking on bladder cancer risk. The Belgian case control study on bladder cancer. Int. J. Cancer, 118, 2572-2578.
42. Thirumaran, R.K., Bermejo, J.L., Rudnai, P., Gurzau, E., Koppova, K., Goessler, W., Vahter, M., Leonardi, G.S., Clemens, F., Fletcher, T. et al. (2006) Single nucleotide polymorphisms inDNArepair genes and basal cell carcinoma of skin. Carcinogenesis, 27, 1676-1681.
43. Larsson, P., Wijkström, H., Thorstenson, A., Adolfsson, J., Norming, U., Wiklund, P., Onelöv, E. and Steineck, G. (2003)Apopulation-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years. Scand. J. Urol. Nephrol., 37, 195-201.
44. Lehmann, M.-L., Selinski, S., Blaszkewicz, M., Orlich, M., Ovsiannikov, D., Moormann, O., Guballa, C., Kress, A., Truss, M.C., Gerullis, H. et al. (2010) Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk. Arch. Toxicol., 84, 967-978.
45. Golka, K., Schmidt, T., Seidel, T., Dietrich, H., Roemer, H.C., Lohlein, D., Reckwitz, T., Sokeland, J., Weistenhofer, W., Blaszkewicz, M. et al. (2008) The influence of polymorphisms of glutathione S-transferasesM1andM3on the development of human urothelial cancer. J. Toxicol. Environ. Health A, 71, 881-886.
46. Golka, K., Hermes, M., Selinski, S., Blaszkewicz, M., Bolt, H.M., Roth, G., Dietrich, H., Prager, H.-M., Ickstadt, K. and Hengstler, J.G. (2009) Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure. Pharmacogenet. Genomics, 19, 903-906.
47. Howie, B.N., Donnelly, P. and Marchini, J. (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet., 5, e1000529.
48. Marchini, J., Howie, B., Myers, S., McVean, G. and Donnelly, P. (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet., 39, 906-913.
49. Kutyavin, I.V., Milesi, D., Belousov, Y., Podyminogin, M., Vorobiev, A., Gorn, V., Lukhtanov, E.A., Vermeulen, N.M.J. and Mahoney, W. (2006) A novel endonuclease IV post-PCR genotyping system. Nucleic Acids Res., 34, e128.
50. Kong, A., Gudbjartsson, D.F., Sainz, J., Jonsdottir, G.M., Gudjonsson, S.A., Richardsson, B., Sigurdardottir, S., Barnard, J., Hallbeck, B., Masson, G. et al. (2002) A high-resolution recombination map of the human genome. Nat. Genet., 31, 241-247.
51. Gretarsdottir, S., Thorleifsson, G., Reynisdottir, S.T., Manolescu, A., Jonsdottir, S., Jonsdottir, T., Gudmundsdottir, T., Bjarnadottir, S.M., Einarsson, O.B., Gudjonsdottir, H.M. et al. (2003) The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet., 35, 131-138.
52. Mantel, N. and Haenszel, W. (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst., 22, 719-748.
53. Higgins, J.P.T. and Thompson, S.G. (2002) Quantifying heterogeneity in a meta-analysis. Stat. Med., 21, 1539-1558.
54. Kapushesky, M., Adamusiak, T., Burdett, T., Culhane, A., Farne, A., Filippov, A., Holloway, E., Klebanov, A., Kryvych, N., Kurbatova, N. et al. (2012) Gene Expression Atlas update-a value-added database of microarray and sequencing-based functional genomics experiments. Nucleic Acids Res., 40, D1077-D1081.
55. El Behi, M., Krumeich, S., Lodillinsky, C., Kamoun, A., Tibaldi, L., Sugano, G., De Reynies, A., Chapeaublanc, E., Laplanche, A., Lebret, T. et al. (2013) An essential role for decorin in bladder cancer invasiveness. EMBO Mol. Med., 5, 1835-1851. doi:10.1002/emmm.201302655.
56. Morgan, R., Bryan, R.T., Javed, S., Launchbury, F., Zeegers, M.P., Cheng, K.K., James, N.D., Wallace, D.M.A., Hurst, C.D., Ward, D.G. et al. (2013) Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. Eur. J. Cancer Oxf. Engl., 49, 2214-2222. doi:10.1016/j.ejca.2013.01.019.
57. Southgate, J., Hutton, K.A., Thomas, D.F. and Trejdosiewicz, L.K. (1994) Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab. Investig. J. Tech. Methods Pathol., 71, 583-594.